Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Tecelra patent?

I’m not finding a well-known drug exactly named “Tecelra.” It could be a misspelling, a brand name, or a newer/regional product. Could you confirm a bit more?

- Is Tecelra the brand name, or do you know the active ingredient (API) or generic name?
- Which country or region are you interested in (e.g., US, EU, WO/PCT, etc.)?
- Do you want a patent landscape (grants, family members, expirations), freedom-to-operate thoughts, or specific patent documents?

If you’d like, I can outline how to locate and analyze the patents yourself. Here’s a quick guide to get you started:

- Identify the correct term: check for alternate spellings or synonyms of the brand/API name, and gather regulatory status (FDA/EMA).
- Patent databases to search: Google Patents, Espacenet (EPO), USPTO, WIPO PATENTSCOPE, and Lens.org.
- Useful search angles:
- Brand name or API name in quotes (e.g., "Tecelra" or "tecelr[a/z]om"?), plus common misspellings.
- If you know the indication, search by indication plus “patent” and the API.
- Look for patent families by the same applicant/assignee; review WO publications first, then national phases (US, EU, etc.).
- What to capture in a report:
- Core patent families (claims on composition, synthesis, and use)
- Key claim scopes and any recent continuations or divisionals
- Patent term adjustments and any pediatric extensions
- Expiration dates and market exclusivity (data/market exclusivity in relevant regions)
- Freedom-to-operate considerations and notable license/settlement data if available

If you can share the exact name or allow me to search, I can pull together a summarized patent landscape with key families, claim highlights, and expiration timelines.